Skip to content
CompoundSci
All peptides
Research vial labelled Glutathione, a Standalone or fussy peptide studied in preclinical and clinical literature

Glutathione

The file here is mostly preclinical work plus clinic and community practice, not registrational trials.

A tripeptide antioxidant, not a signalling peptide. It oxidises quickly once reconstituted, so short storage windows matter here.

General profile

Class
Standalone or fussy
Evidence
Mixed or moderate evidence
Studied dose range
100–600 mg
Frequency in protocols
1–3× weekly
Route
Subcutaneous or intravenous
Half life
~10 minutes systemically
Reconstitution
5 mL bacteriostatic water per 600 mg vial
Storage
Refrigerated, light-protected, ~14 days

Timing and cycling in the literature

Usually dosed in the morning window

One to three times weekly

It oxidises fast once reconstituted and must be kept light-protected. Never mix it in a barrel with anything else.

Reported cycle: 8 weeks on, 4 weeks off

Clinic courses run weekly to three times weekly in blocks alongside other antioxidant support.

Watch for: It oxidises fast once reconstituted. Discard it early rather than pushing the storage window.

What it conflicts with

Three separate questions, kept separate. A hard stop means the mechanisms must not run together at all and timing does not fix it. A syringe rule means the same day is fine but one barrel is not. Redundancy is not dangerous, it is paying twice to hit one target.

  • Separate syringesSame day fine, same syringe not

    Glutathione + GHK-Cu

    Never in one barrel

    Glutathione chelates and reduces copper, so it can strip the copper that makes GHK-Cu work at all. Same day is fine. Same syringe destroys the point of the dose.

  • Separate syringesSame day fine, same syringe not

    Glutathione + Any copper peptide

    Own line near copper compounds

    Glutathione strips copper out of copper peptide complexes. Keep it away from GHK-Cu and any GHK-containing blend in the barrel.

Most syringe compatibility claims here are practice and expert consensus, not peer reviewed mixing studies. A clear liquid after mixing does not prove the compounds are still active, and cloudiness, particles or gelling means discard. Active cancer, pregnancy, major cardiac care and heavy immunosuppression override every stack preference on this page.

See how Glutathione fits your week

The injection scheduler spaces doses using the clinical timing data, flags the pairs above before you draw them, and tells you why.

Model this in the injection scheduler

The studies

Human trials: No completed human efficacy trial that establishes a dose for the use people are chasing.

Open questions: Treat published dosing as observed practice, not a validated protocol.

Published papers

Indexed from Europe PMC and refreshed weekly. Each link opens the paper itself.

Search the full literature